Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Carcinoid Tumor peptide trials
2 selected ClinicalTrials.gov records carrying the official condition label Carcinoid Tumor. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
2 selected records.
1 profiles.
2016–2020 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 30 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Carcinoid Tumor unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00446082
PeptideScanner retained ClinicalTrials.gov record NCT00446082 at 2026-11-15T22:05:38.400Z. Its registry update date was 2020-12-21, and PeptideScanner's reviewed identity mapping was pasireotide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- December 21, 2020
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00804336
PeptideScanner retained ClinicalTrials.gov record NCT00804336 at 2026-11-15T22:05:38.400Z. Its registry update date was 2016-10-19, and PeptideScanner's reviewed identity mapping was pasireotide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- October 19, 2016
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Pasireotide · 2020-12-21
ClinicalTrials.gov record NCT00446082
Completed at the retained observation.
Open attributed record →Pasireotide · 2016-10-19
ClinicalTrials.gov record NCT00804336
Completed at the retained observation.
Open attributed record →